Gene · 3978
Papers1,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SMYD3 promotes endometrial cancer through epigenetic regulation of LIG4/XRCC4/XLF complex in non-homologous end joining repair. | Oncogenesis | 2024 | 38191478 | PubTator, text mining | PubMed |
| Structure-guided design of a selective inhibitor of the methyltransferase KMT9 with cellular activity. | Nat Commun | 2024 | 38167811 | PubTator, text mining | PubMed |
| Decline of DNA damage response along with myogenic differentiation. | Life Sci Alliance | 2024 | 37993260 | PubTator, text mining | PubMed |
| ClinicalOmicsDB: exploring molecular associations of oncology drug responses in clinical trials. | Nucleic Acids Res | 2024 | 37811874 | PubTator, text mining | PubMed |
| Mammalian DNA ligases; roles in maintaining genome integrity. | J Mol Biol | 2024 | 37714297 | PubTator, text mining | PubMed |
| Genetics and clinical phenotypes in common variable immunodeficiency. | Front Genet | 2023 | 38274105 | PubTator, text mining | PubMed |
| Canonical binding of Chaetomium thermophilum DNA polymerase δ/ζ subunit PolD3 and flap endonuclease Fen1 to PCNA. | Front Mol Biosci | 2023 | 38223238 | PubTator, text mining | PubMed |
| CYP1B1 promotes colorectal cancer liver metastasis by enhancing the growth of metastatic cancer cells via a fatty acids-dependent manner. | J Gastrointest Oncol | 2023 | 38196537 | PubTator, text mining | PubMed |
| 27-hydroxycholesterol and DNA damage repair: implication in prostate cancer. | Front Oncol | 2023 | 38188290 | PubTator, text mining | PubMed |
| Duplication at 19q13.32q13.33 Segregating with Neuropsychiatric Phenotype in a Three-Generation Family: Towards the Definition of a Critical Region. | Genes (Basel) | 2023 | 38136979 | PubTator, text mining | PubMed |
| hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal adenocarcinoma. | Mol Cancer | 2023 | 38044421 | PubTator, text mining | PubMed |
| Extrachromosomal DNA (ecDNA): Unveiling its role in cancer progression and implications for early detection. | Heliyon | 2023 | 38027570 | PubTator, text mining | PubMed |
| Cas9 is mostly orthogonal to human systems of DNA break sensing and repair. | PLoS One | 2023 | 38019812 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response for Cancer Therapy. | Int J Mol Sci | 2023 | 37958890 | PubTator, text mining | PubMed |
| Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer. | Sci Rep | 2023 | 37950047 | PubTator, text mining | PubMed |
| TDP1 suppresses chromosomal translocations and cell death induced by abortive TOP1 activity during gene transcription. | Nat Commun | 2023 | 37945566 | PubTator, text mining | PubMed |
| Identification of functional lncRNAs in atrial fibrillation based on RNA sequencing. | BMC Cardiovasc Disord | 2023 | 37932671 | PubTator, text mining | PubMed |
| Overexpression of XRCC1 is Associated with Poor Survival in Patients with Head and Neck Squamous Carcinoma and Has Potential to Be Used as Targeted Therapy by Synthetic Lethality. | Asian Pac J Cancer Prev | 2023 | 37898859 | PubTator, text mining | PubMed |
| ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification. | J Biol Chem | 2023 | 37898399 | PubTator, text mining | PubMed |
| Effect of Long-Term Low-Dose Arsenic Exposure on DNA Methylation and Gene Expression in Human Liver Cells. | Int J Mol Sci | 2023 | 37894918 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3978/papers?page=6